Endpoints News ٢٧ مارس ٢٠٢٦ Novartis to spend up to $2B on Excellergy and its next-gen Xolair candidate
Endpoints News ٢٥ مارس ٢٠٢٦ Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News ٢٣ مارس ٢٠٢٦ Novartis to invest $480M in China following AstraZeneca and Lilly pledges
Endpoints News ٢٠ مارس ٢٠٢٦ Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Endpoints News ١٦ مارس ٢٠٢٦ After Novartis pact, macrocycle shop Unnatural Products gets $45M Series B
Endpoints News ٢٦ فبراير ٢٠٢٦ Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News ٢٠ فبراير ٢٠٢٦ Novartis to divest India unit to private equity-led consortium for $159M
Endpoints News ١٨ فبراير ٢٠٢٦ Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News ١٨ فبراير ٢٠٢٦ Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
Endpoints News ١٣ يناير ٢٠٢٦ Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News ١٢ يناير ٢٠٢٦ Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s